Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

12:35 PM - 12:40 PM ET

1109 - Pre-Treatment Diagnostic and Staging Efficiency in Patients with Non-Small Cell Lung Cancer (NSCLC): A Systems Operations Audit in an Integrated Health System
Speaker: Mohindra, Pranshu, MD, MMM, FABS - University Hospitals Seidman Cancer Center, Cleveland, OH, Cleveland, OH
12:35 PM - 12:40 PM ET

1116 - The Role of Advanced Practice Providers in Functional Radiotherapy
Speaker: Mullins, Marissa, BSN, DNP - Loyola University Medical Center, Maywood, IL
12:39 PM - 12:48 PM ET

256 - BEYOND PAIN SCORES: PHOTOBIOMODULATION REDUCES ANALGESIC BURDEN AND IMPROVES TREATMENT TOLERANCE DURING CHEMORADIOTHERAPY FOR ORAL CAVITY CANCER
Speaker: Nanda, Siddhartha, MD, MBBS - All India Institute of Medical Sciences, Raipur, Chhattisgarh
12:40 PM - 12:45 PM ET

1110 - Assessing Insurer Market Share Association with Insurance Denials, Appeals, and Prolonged Prior Authorization for Patients Undergoing Proton Beam Therapy
Speaker: Randolph, Allison, MD, MBA - Johns Hopkins Medicine, Baltimore, MD
12:40 PM - 12:45 PM ET

1117 - Improving Radiation Oncology Nursing Competence through a Structured, Needs-Based Education Initiative
Speaker: Gay, Kailey, MSN, OCN, RN - Moffitt Cancer Center, Tampa, FL
12:40 PM - 12:50 PM ET

238 - Targeting Recurrent Glioblastoma with Stereotactic Radiosurgery and Tumor Treating Fields Guided by 18F-FET-PET: Long-Term Results from a Prospective Phase 2 Trial (TTaRGeT)
Speaker: Harat, Maciej, MD, PhD - Franciszek Lukaszczyk Oncology Center, Bydgoszcz, Kujawsko-Pomorsk
12:40 PM - 12:50 PM ET

244 - Cure Estimation using Reconstructed Kaplan-Meier Analyses in Randomized Phase III Oncology Trials (CUREMA): A Meta-Epidemiological Study
Speaker: Chauhan, Kimi, MD, BS, MTM - Mayo Clinic College of Medicine and Science Rochester, Rochester, MN
12:40 PM - 12:50 PM ET

250 - The Role of Docetaxel in Addition to Salvage Radiation and Androgen Deprivation in Men with High-Risk Prostate Cancer Post-Prostatectomy: Results of NRG GU002
Speaker: Hurwitz, Mark, MD, FASTRO - New York Medical College/Westchester Medical Center Health, Valhalla, NY
12:40 PM - 12:50 PM ET

261 - Clinical and Genomic Landscape of Recurrence After Concurrent Chemoradiotherapy and Adjuvant Immunotherapy in Unresectable NSCLC
Speaker: Olabode, Kolade, MD, MPH - Moffitt Cancer Center, Tampa, FL
12:40 PM - 12:50 PM ET

267 - Inter-Individual Variability in Thoracic vs. Abdominal Breathing Patterns Limits Generic SGRT Tracking in DIBH: A Prospective Optical Motion Capture Study
Speaker: Yousuf, Mohamed, PhD - Thomas Jefferson University, Philadelphia, PA
12:40 PM - 12:50 PM ET

274 - Osimertinib Combined with Stereotactic Body Radiotherapy vs. Osimertinib Alone in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase II Randomized Controlled Trial
Speaker: Zheng, Xiaoli, MD - The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Beijing, Beijing
12:45 PM - 12:50 PM ET

1111 - Building a Scalable Radiation Oncology Access Database: Lessons from a Geospatial Analysis of Oregon
Speaker: Butler, John, MD, PhD - University of California San Diego, San Diego, CA